Rchr
J-GLOBAL ID：201801011271575815
Update date: Jun. 17, 2024
Horibe Keizo
ホリベ ケイゾウ | Horibe Keizo
Affiliation and department：
Job title：
Part-time Doctor
Research field (1)：
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (11)：
- 2015 - 2019 An approach to establish pediatric hereditary cancer-related biomarkers applying DNA damage repair factors
- 2012 - 2015 Basic Research to Establish the School Re-Entry Support Program for Children with Cancer
- 2012 - 2015 Exploration for therapeutic target using a novel prognostic factor IKZF1 targeting cells in childhood acute lymphoblastic leukemia
- 2010 - 2012 STUDY OF MINIMAL RESIDUAL DISEASE MEASUREMENTS AND CLINICAL APPLICATION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
- 2000 - 2002 Study on mechanism of ATRA-resistance and utility of MRD-monitoring in acute promyelocytic leukemia
- 1996 - 1998 Prognostic significance of molecular detection of minimal residual disease in childhood acute lymphoblastic leukemia
- 1996 - 1996 白血病に関わる染色体転座部位の構造解析による転座メカニズム研究
- 1995 - 1995 治療関連二次性白血病の発症にかかわる染色体転座機構の研究
- 1993 - 1995 Basic study for clinical application of anti-ganglioside D2 monoclonal antibody against neuroblastoma
- 1993 - 1994 The study of opportunistic infection route and prevention on children with leukemia.
- 1992 - 1994 Research on molecular diagnosis of viral encephalitis in children -application to early diagnosis-
Show all
Papers (82)：
-
Mayumi Hangai, Takahisa Kawaguchi, Masatoshi Takagi, Keitaro Matsuo, Soyoung Jeon, Charleston W K Chiang, Andrew T Dewan, Adam J De Smith, Toshihiko Imamura, Yasuhiro Okamoto, et al. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients. Haematologica. 2024. 109. 4. 1247-1252
-
Hideaki Ueki, Chitose Ogawa, Hiroaki Goto, Masanori Nishi, Junko Yamanaka, Shinji Mochizuki, Takuro Nishikawa, Tadashi Kumamoto, Ritsuo Nishiuchi, Atsushi Kikuta, et al. TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia. International journal of hematology. 2024. 119. 4. 450-458
-
Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki, Rika Kanezaki, Kiminori Terui, Ryunosuke Saiki, Masami Ojima, Yotaro Ochi, Seiya Mizuno, Masaharu Yoshihara, et al. Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms. Blood. 2024
-
Michihiro Hidaka, Koiti Inokuchi, Nobuhiko Uoshima, Naoto Takahashi, Nao Yoshida, Shuichi Ota, Hirohisa Nakamae, Hiromi Iwasaki, Kenichiro Watanabe, Yoshiyuki Kosaka, et al. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Japanese journal of clinical oncology. 2024. 54. 2. 153-159
-
Reiji Fukano, Yuka Iijima-Yamashita, Hideto Iwafuchi, Atsuko Nakazawa, Akiko M Saito, Tetsuya Takimoto, Masahiro Sekimizu, Yutaka Suehiro, Takahiro Yamasaki, Shunji Hasegawa, et al. Prognostic value of minimal disseminated disease assessed using digital polymerase chain reaction for 3'ALK assays in pediatric anaplastic lymphoma kinasepositive anaplastic large cell lymphoma. Haematologica. 2024. 109. 2. 652-656
ｍore...
MISC (2)：
-
古井辰郎, 高井泰, 木村文則, 北島道夫, 中塚幹也, 森重健一郎, 山本一仁, 橋本大哉, 松本公一, 大園誠一郎, et al. Current Status of Oncofertility in Adolescent and Young Adult (AYA) Generation Cancer Patients in Japan-National Survey of Oncologists. 癌と化学療法. 2018. 45. 5. 841-846-846
-
齋藤 俊樹, 関水 匡大, 嘉田 晃子, 齋藤 明子, 伊藤 典子, 橋本 大哉, 山本 松雄, 堀部 敬三. 研究相談の需要調査と実施体制の確立について. 国立病院総合医学会講演抄録集. 2017. 71回. 1010-1010
Return to Previous Page
